|
LOC400927 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.730600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.492200E-01 |
| Normal-vs-Stage2 |
7.416400E-01 |
| Normal-vs-Stage3 |
9.775600E-01 |
| Normal-vs-Stage4 |
8.792600E-01 |
| Stage1-vs-Stage2 |
8.246000E-01 |
| Stage1-vs-Stage3 |
8.532800E-01 |
| Stage1-vs-Stage4 |
7.045000E-01 |
| Stage2-vs-Stage3 |
7.410600E-01 |
| Stage2-vs-Stage4 |
6.598400E-01 |
| Stage3-vs-Stage4 |
8.536400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.159600E-01 |
| Normal-vs-AfricanAmerican |
8.442200E-02 |
| Normal-vs-Asian |
6.087600E-02 |
| Caucasian-vs-AfricanAmerican |
2.920200E-02 |
| Caucasian-vs-Asian |
8.417700E-02 |
| AfricanAmerican-vs-Asian |
4.316800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.376600E-01 |
| Normal-vs-Female |
1.796780E-01 |
| Male-vs-Female |
7.276500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.622800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.888400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.941000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.909000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.700800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.155400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.148600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.510200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.568200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.110400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.323100E-03 |
| Normal-vs-Grade 2 |
3.548200E-01 |
| Normal-vs-Grade 3 |
5.424600E-01 |
| Normal-vs-Grade 4 |
3.500200E-01 |
| Grade 1-vs-Grade 2 |
1.203810E-02 |
| Grade 1-vs-Grade 3 |
2.159400E-04 |
| Grade 1-vs-Grade 4 |
2.335500E-03 |
| Grade 2-vs-Grade 3 |
4.750500E-02 |
| Grade 2-vs-Grade 4 |
6.536200E-02 |
| Grade 3-vs-Grade 4 |
5.806600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.408000E-01 |
| Normal-vs-ccB subtype |
2.614200E-01 |
| ccA subtype-vs-ccB subtype |
1.080030E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.139400E-01 |
| Normal-vs-N1 |
1.701760E-01 |
| N0-vs-N1 |
3.049900E-02 |
|
|
